These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

155 related items for PubMed ID: 3989379

  • 1. Increased plasma cholestanol and 5 alpha-saturated plant sterol derivatives in subjects with sitosterolemia and xanthomatosis.
    Salen G, Kwiterovich PO, Shefer S, Tint GS, Horak I, Shore V, Dayal B, Horak E.
    J Lipid Res; 1985 Feb; 26(2):203-9. PubMed ID: 3989379
    [Abstract] [Full Text] [Related]

  • 2. Increased plasma plant sterol levels in heterozygotes with sitosterolemia and xanthomatosis.
    Hidaka H, Nakamura T, Aoki T, Kojima H, Nakajima Y, Kosugi K, Hatanaka I, Harada M, Kobayashi M, Tamura A.
    J Lipid Res; 1990 May; 31(5):881-8. PubMed ID: 2380636
    [Abstract] [Full Text] [Related]

  • 3. Dietary sitostanol and campestanol: accumulation in the blood of humans with sitosterolemia and xanthomatosis and in rat tissues.
    Connor WE, Lin DS, Pappu AS, Frohlich J, Gerhard G.
    Lipids; 2005 Sep; 40(9):919-23. PubMed ID: 16331855
    [Abstract] [Full Text] [Related]

  • 4. Identification of 5 alpha-stanols in patients with sitosterolemia and xanthomatosis: stereochemistry of the protonolysis of steroidal organoboranes.
    Dayal B, Tint GS, Batta AK, Speck J, Khachadurian AK, Shefer S, Salen G.
    Steroids; 1982 Aug; 40(2):233-43. PubMed ID: 6297129
    [Abstract] [Full Text] [Related]

  • 5. Lethal atherosclerosis associated with abnormal plasma and tissue sterol composition in sitosterolemia with xanthomatosis.
    Salen G, Horak I, Rothkopf M, Cohen JL, Speck J, Tint GS, Shore V, Dayal B, Chen T, Shefer S.
    J Lipid Res; 1985 Sep; 26(9):1126-33. PubMed ID: 4067433
    [Abstract] [Full Text] [Related]

  • 6. High levels of plant sterols and cholesterol precursors in cerebrotendinous xanthomatosis.
    Kuriyama M, Fujiyama J, Kasama T, Osame M.
    J Lipid Res; 1991 Feb; 32(2):223-9. PubMed ID: 2066659
    [Abstract] [Full Text] [Related]

  • 7. Comparison of the intestinal uptake of cholesterol, plant sterols, and stanols in mice.
    Igel M, Giesa U, Lutjohann D, von Bergmann K.
    J Lipid Res; 2003 Mar; 44(3):533-8. PubMed ID: 12562824
    [Abstract] [Full Text] [Related]

  • 8. A unique patient with coexisting cerebrotendinous xanthomatosis and beta-sitosterolemia.
    Wang C, Lin HJ, Chan TK, Salen G, Chan WC, Tse TF.
    Am J Med; 1981 Aug; 71(2):313-9. PubMed ID: 7258222
    [Abstract] [Full Text] [Related]

  • 9. Regulation of cholesterol biosynthesis in sitosterolemia: effects of lovastatin, cholestyramine, and dietary sterol restriction.
    Nguyen LB, Cobb M, Shefer S, Salen G, Ness GC, Tint GS.
    J Lipid Res; 1991 Dec; 32(12):1941-8. PubMed ID: 1816322
    [Abstract] [Full Text] [Related]

  • 10. Competitive inhibition of bile acid synthesis by endogenous cholestanol and sitosterol in sitosterolemia with xanthomatosis. Effect on cholesterol 7 alpha-hydroxylase.
    Shefer S, Salen G, Nguyen L, Batta AK, Packin V, Tint GS, Hauser S.
    J Clin Invest; 1988 Dec; 82(6):1833-9. PubMed ID: 3143743
    [Abstract] [Full Text] [Related]

  • 11. Intestinal cholesterol absorption inhibitor ezetimibe added to cholestyramine for sitosterolemia and xanthomatosis.
    Salen G, Starc T, Sisk CM, Patel SB.
    Gastroenterology; 2006 May; 130(6):1853-7. PubMed ID: 16697747
    [Abstract] [Full Text] [Related]

  • 12. Abnormal metabolism of shellfish sterols in a patient with sitosterolemia and xanthomatosis.
    Gregg RE, Connor WE, Lin DS, Brewer HB.
    J Clin Invest; 1986 Jun; 77(6):1864-72. PubMed ID: 3711338
    [Abstract] [Full Text] [Related]

  • 13. Response to diet and cholestyramine in a patient with sitosterolemia.
    Belamarich PF, Deckelbaum RJ, Starc TJ, Dobrin BE, Tint GS, Salen G.
    Pediatrics; 1990 Dec; 86(6):977-81. PubMed ID: 2251034
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Increased sitosterol absorption, decreased removal, and expanded body pools compensate for reduced cholesterol synthesis in sitosterolemia with xanthomatosis.
    Salen G, Shore V, Tint GS, Forte T, Shefer S, Horak I, Horak E, Dayal B, Nguyen L, Batta AK.
    J Lipid Res; 1989 Sep; 30(9):1319-30. PubMed ID: 2600539
    [Abstract] [Full Text] [Related]

  • 16. Effects of unsaturated and saturated dietary plant sterols on their serum contents.
    Vanhanen HT, Miettinen TA.
    Clin Chim Acta; 1992 Jan 31; 205(1-2):97-107. PubMed ID: 1521345
    [Abstract] [Full Text] [Related]

  • 17. Hyperabsorption and retention of campestanol in a sitosterolemic homozygote: comparison with her mother and three control subjects.
    Salen G, Xu G, Tint GS, Batta AK, Shefer S.
    J Lipid Res; 2000 Nov 31; 41(11):1883-9. PubMed ID: 11060358
    [Abstract] [Full Text] [Related]

  • 18. A marked and sustained reduction in LDL sterols by diet and cholestyramine in beta-sitosterolemia.
    Parsons HG, Jamal R, Baylis B, Dias VC, Roncari D.
    Clin Invest Med; 1995 Oct 31; 18(5):389-400. PubMed ID: 8529322
    [Abstract] [Full Text] [Related]

  • 19. Similar serum plant sterol responses of human subjects heterozygous for a mutation causing sitosterolemia and controls to diets enriched in plant sterols or stanols.
    Kratz M, Kannenberg F, Gramenz E, Berning B, Trautwein E, Assmann G, Rust S.
    Eur J Clin Nutr; 2007 Jul 31; 61(7):896-905. PubMed ID: 17228349
    [Abstract] [Full Text] [Related]

  • 20. Effects of an HMG-CoA reductase inhibitor, pravastatin, and bile sequestering resin, cholestyramine, on plasma plant sterol levels in hypercholesterolemic subjects.
    Hidaka H, Kojima H, Kawabata T, Nakamura T, Konaka K, Kashiwagi A, Kikkawa R, Shigeta Y.
    J Atheroscler Thromb; 1995 Jul 31; 2(1):60-5. PubMed ID: 9225210
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.